Phase Ⅱ and Ⅲ Trial of a SARS-CoV-2 Vaccine LYB001

NCT05137444 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

1900

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: LYB001
BIOLOGICAL: Placebo

Sponsor

Yantai Patronus Biotech Co., Ltd.